Skip to main content
Caplight Logo









Acculi Labs

Acculi Labs

Private
BangaloreHealthcare & Life Scienceshttps://lyfas.net/

Last Round

VC Round

Aug 1, 2024

Est. Valuation

$25M

Total Funding Raised

$922,000

Company Overview

Acculi Labs is a healthtech company that provides a clinical-grade, non-invasive digital biomarker platform called Lyfas for early disease detection and chronic disease monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Health IoT, Healthcare Analytics, Telemedicine, InsurTech

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

non-invasive diagnosticsremote patient monitoringAI diagnosticsdigital biomarkersmedical AItelemedicinevirtual carehealth-techphotoplethysmographymobile healthPPGmHealthhealth IoTInsurTechpreventive healthcareclinical decision supportusage-based API

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Acculi Labs Comparables

Compare Acculi Labs with similar companies based on industry and business-model similarity.

Acculi Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FaceHeart
81%
Happitech
81%
Shen AI
80%

Acculi Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 1, 2024
SeedOct 31, 2022
Convertible DebtAug 4, 2021
SeedOct 5, 2020
GrantJul 28, 2020
Pre Seed
Sep 12, 2019

Acculi Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 31, 2022

    Received funding from Startup Incubation And Innovation Centre, IIT Kanpur.

  • Aug 4, 2021

    $125K raised in convertible debt financing.

Acculi Labs Filings

Explore SEC and related filing metadata, where available.

Acculi Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Acculi Labs's valuation, stock price, and market status.

Is Acculi Labs a public or private company?

Acculi Labs is a private company.

What is the current stock price of Acculi Labs?

Acculi Labs is a private company, so its shares have no public market price. Caplight tracks Acculi Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Acculi Labs worth (valuation)?

Acculi Labs's valuation is estimated at $25.0M based on funding round data.

Can I buy Acculi Labs stock?

Acculi Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Acculi Labs's last funding round?

Acculi Labs's most recent funding round was VC Round on August 1, 2024.

Who are the main investors in Acculi Labs?

Key investors in Acculi Labs include Sabi Holding India.

Will Acculi Labs IPO soon?

No public IPO plans have been announced for Acculi Labs.

How can I track Acculi Labs secondary market activity?

Caplight tracks bids, offers, and trades in Acculi Labs's shares on secondary markets.

Firmographic Details

HeadquartersBangalore
Year Founded2017
Last FundingAug 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?